Recruiting Neuromyelitis Optica Studies in Chapel Hill
About Neuromyelitis Optica Clinical Trials in Chapel Hill
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease that primarily attacks the optic nerves and spinal cord, causing vision loss and paralysis. It is distinct from multiple sclerosis and often involves aquaporin-4 antibodies. Treatment includes immunosuppressive therapies and biologics.
There are currently 2 neuromyelitis optica clinical trials recruiting participants in Chapel Hill, NC. These studies are seeking a combined 303 participants. Research is being sponsored by Alexion Pharmaceuticals, Inc., Ad scientiam. Clinical trial participation is free and participants receive study-related medical care at no cost.
Neuromyelitis Optica Clinical Trials in Chapel Hill — FAQ
Are there neuromyelitis optica clinical trials in Chapel Hill?
Yes, there are 2 neuromyelitis optica clinical trials currently recruiting in Chapel Hill, NC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chapel Hill?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chapel Hill research site will contact you about next steps.
Are clinical trials in Chapel Hill free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chapel Hill studies also compensate for your time and travel.
What neuromyelitis optica treatments are being tested?
The 2 active trials in Chapel Hill are testing new therapies including novel drugs, biologics, and treatment approaches for neuromyelitis optica.
Data updated October 18, 2026 from ClinicalTrials.gov